Health Sciences

Fragile X syndrome (FXS) is the most common genetically inherited cause of intellectual disability in humans.

Josep Dalmau, MD, PhD, an adjunct professor of neurology and founder and director of the Penn Center of Autoimmune Neurology in the Perelman School of Medicine at the University of Pennsylvania, was honored as a recipient of the American Academy of Neurology’s 2016 Cotzias Lecture and Award, at the organization’s 68th annual meeting that took place April 15-21 in Vancouver.

Even those who have never had a CT scan are likely familiar with the process, which often entails a slow journey through a narrow tube. Given that the experience can elicit feelings of claustrophobia in human adults, it’s easy to imagine how complicated it can be to perform the same procedure on a 1,400 pound horse.

On top of the meaning and mystery that humans heap on the heart, it is first and foremost, a muscle. And one that beats about once a second for a person’s entire life, with no rest. Given its vital importance, it’s ironic researchers have only recently made direct observations of its subcellular parts in motion.

Beatrice H.

University of Pennsylvania President Amy Gutmann today announced the selection of four undergraduates as the inaugural President’s Innovation Prize recipients.

Asthma is an enormous public health problem that continues to grow larger, in part because scientists don’t fully understand how it is caused. Existing therapies don’t cure the disease and often don’t even significantly alleviate the symptoms.

Immune cells engineered to seek out and attack a type of deadly brain cancer known as glioblastoma (GBM) were found to have an acceptable safety profile and successfully migrate to and infiltrate tumors, researchers from Penn Medicine and Harvard University reported at the

Results from the I-SPY 2 trial show that giving patients with HER2-positive invasive breast cancer a combination of the drugs trastuzumab emtansine (T-DM1) and pertuzumab  before surgery was more beneficial than the combination of paclitaxel plus trastuzumab.

After a kidney transplant, women may experience decreased kidney damage from ischemia reperfusion injury compared to men due to the impact of gender-specific hormones, suggests a new preclinical study and an analysis of patient data published online in the Journal of Clinical Investigation